168 related articles for article (PubMed ID: 36419200)
21. Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: A comparative study.
Doghaim NN; Gheida SF; El-Tatawy RA; Mohammed Ali DA
J Cosmet Dermatol; 2019 Feb; 18(1):142-149. PubMed ID: 29707867
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of using oral methotrexate with phototherapy in the treatment of vitiligo in comparison with single phototherapy treatment: A double-blinded randomized controlled trial.
Lajevardi V; Hosseini ZSS; Heidari S
Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):657-662. PubMed ID: 37859524
[TBL] [Abstract][Full Text] [Related]
23. Comparison of efficacy and safety profile for home NB-UVB vs. outpatient NB-UVB in the treatment of non-segmental vitiligo: A prospective cohort study.
Zhang L; Wang X; Chen S; Zhao J; Wu J; Jiang M; Zhang C; Xiang L
Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):261-267. PubMed ID: 30854736
[TBL] [Abstract][Full Text] [Related]
24. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
25. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
26. Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients.
Farag AGA; Hammam MA; Al-Sharaky DR; El-Boghdady GM
An Bras Dermatol; 2019; 94(4):434-441. PubMed ID: 31644616
[TBL] [Abstract][Full Text] [Related]
27. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.
Ibrahim H; El Taieb M; El Gamel Z; El Saied AR
J Cosmet Dermatol; 2018 Oct; 17(5):911-916. PubMed ID: 29524288
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of bimatoprost ophthalmic solution combined with NB-UVB phototherapy in non-segmental and segmental vitiligo: a single-blind randomized controlled study.
Silpa-Archa N; Likittanasombat S; Apinuntham C; Pruksaeakanan C; Charoenpipatsin N; Chaiyabutr C; Wongpraparut C
Sci Rep; 2023 Apr; 13(1):6438. PubMed ID: 37081101
[TBL] [Abstract][Full Text] [Related]
29. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
30. Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study.
Khemis A; Fontas E; Moulin S; Montaudié H; Lacour JP; Passeron T
J Invest Dermatol; 2020 Aug; 140(8):1533-1537.e2. PubMed ID: 32004567
[TBL] [Abstract][Full Text] [Related]
31. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
[TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
Khullar G; Kanwar AJ; Singh S; Parsad D
J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
[TBL] [Abstract][Full Text] [Related]
33. A comparative study on the use of fractional CO
Bakr RM; Abdel-Gaber RM; Tawfik YM
Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
[TBL] [Abstract][Full Text] [Related]
34. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo.
Akdeniz N; Yavuz IH; Gunes Bilgili S; Ozaydın Yavuz G; Calka O
J Dermatolog Treat; 2014 Jun; 25(3):196-9. PubMed ID: 23441902
[TBL] [Abstract][Full Text] [Related]
35. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of narrowband UVB treatment in pediatric vitiligo: a retrospective analysis of 26 cases.
Yazici S; Günay B; Başkan EB; Aydoğan K; Saricaoğlu H; Tunali Ş
Turk J Med Sci; 2017 Apr; 47(2):381-384. PubMed ID: 28425237
[TBL] [Abstract][Full Text] [Related]
37. Home vs hospital narrowband UVB treatment by a hand-held unit for new-onset vitiligo: A pilot randomized controlled study.
Liu B; Sun Y; Song J; Wu Z
Photodermatol Photoimmunol Photomed; 2020 Jan; 36(1):14-20. PubMed ID: 31206787
[TBL] [Abstract][Full Text] [Related]
38. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
39. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
Zabolinejad N; Maleki M; Salehi M; Ashrafi Z; Molkara S; Layegh P
Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
[TBL] [Abstract][Full Text] [Related]
40. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison.
Eşme P; Gür Aksoy G; Elçin G
Dermatol Surg; 2019 Dec; 45(12):1627-1634. PubMed ID: 30829772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
